Publication Name	World Journal of Cardiology
Manuscript ID	61460
Country	United States

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Meta-Analysis
Article Title	Dabigatran, rivaroxaban, and apixaban are superior to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis
Manuscript Source	Invited Manuscript
All Author List	Wei-Jia Li, Paraschos Archontakis-Barakakis, Leonidas Palaiodimos, Dimitrios Kalaitzoglou, Lazaros Tzelves, Apostolos Manolopoulos, Yu-Chiang Wang, Stefanos Giannopoulos, Robert Faillace and Damianos G Kokkinidis
Funding Agency and Grant Number
Corresponding Author	Damianos G Kokkinidis, MD, MSc, Academic Fellow, Doctor, Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, 1300 Morris Park Ave, Bronx, NY 10461, United States. damiankokki@gmail.com
Key Words	Novel oral anticoagulant; Direct oral anticoagulant; Atrial fibrillation; Asian population; Dabigatran; Rivaroxaban; Apixaban; Warfarin
Core Tip	Dabigatran, rivaroxaban, apixaban have better efficacy (reduction in ischemic stroke and all-cause mortality) and are safer (reduction in major bleeding) than warfarin. Dabigatran is associated with a lower rate of intracranial hemorrhage than warfarin, while rivaroxaban and apixaban appear to have a trend towards reduced intracranial hemorrhage, without statistical significance. Dabigatran, rivaroxaban, and apixaban are associated with a lower rate of gastrointestinal bleeding.
Citation	Li WJ, Archontakis-Barakakis P, Palaiodimos L, Kalaitzoglou D, Tzelves L, Manolopoulos A, Wang YC, Giannopoulos S, Faillace R, Kokkinidis DG. Dabigatran, rivaroxaban, and apixaban compared to warfarin in Asian patients with non-valvular atrial fibrillation: An updated meta-analysis. World J Cardiol 2021; 13(4): 82-94

Received	2020-12-08 02:59
Peer-Review Started	2020-12-08 03:00
To Make the First Decision
Return for Revision	2021-02-15 00:18
Revised	2021-02-21 22:32
Second Decision	2021-04-06 11:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2021-04-14 04:44
Articles in Press	2021-04-14 04:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2021-04-19 00:40

ISSN	1949-8462 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com